Medical Care
Global Antibody Therapeutic Drug Services Market Research Report 2025
- Jun 11, 25
- ID: 303696
- Pages: 89
- Figures: 84
- Views: 4
The global market for Antibody Therapeutic Drug Services was valued at US$ 541 million in the year 2024 and is projected to reach a revised size of US$ 710 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Antibody Therapeutic Drug Services refer to integrated solutions for the development, production, and optimization of antibody-based drugs, offered to biopharmaceutical companies and research institutions. These services span antibody discovery, humanization, efficacy evaluation, process development, and GMP manufacturing, aiming to accelerate clinical translation and commercialization. Typically provided by specialized biotech firms or CROs (Contract Research Organizations), they play a pivotal role in advancing innovative antibody therapies.
North American market for Antibody Therapeutic Drug Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antibody Therapeutic Drug Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Antibody Therapeutic Drug Services in Monoclonal Antibody is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Antibody Therapeutic Drug Services include MtoZ-Biolabs, Charles River Laboratories, GenScript, Coriolis Pharma, Alloy Therapeutics, ProBio, Medicilon, GENECHEM, Shanghai InnoStar Bio-tech, SinoBiological, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antibody Therapeutic Drug Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Therapeutic Drug Services.
The Antibody Therapeutic Drug Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Therapeutic Drug Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Therapeutic Drug Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MtoZ-Biolabs
Charles River Laboratories
GenScript
Coriolis Pharma
Alloy Therapeutics
ProBio
Medicilon
GENECHEM
Shanghai InnoStar Bio-tech
SinoBiological
Wuxi Biologics
Abace Biotechnology
Levena Biopharma
XtalPi
Segment by Type
Antibody Drug Analysis Service
Antibody Drug Development Service
Others
Segment by Application
Monoclonal Antibody
Bisclonal Antibody
ADC
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Therapeutic Drug Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antibody Therapeutic Drug Services refer to integrated solutions for the development, production, and optimization of antibody-based drugs, offered to biopharmaceutical companies and research institutions. These services span antibody discovery, humanization, efficacy evaluation, process development, and GMP manufacturing, aiming to accelerate clinical translation and commercialization. Typically provided by specialized biotech firms or CROs (Contract Research Organizations), they play a pivotal role in advancing innovative antibody therapies.
North American market for Antibody Therapeutic Drug Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antibody Therapeutic Drug Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Antibody Therapeutic Drug Services in Monoclonal Antibody is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Antibody Therapeutic Drug Services include MtoZ-Biolabs, Charles River Laboratories, GenScript, Coriolis Pharma, Alloy Therapeutics, ProBio, Medicilon, GENECHEM, Shanghai InnoStar Bio-tech, SinoBiological, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antibody Therapeutic Drug Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Therapeutic Drug Services.
The Antibody Therapeutic Drug Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Therapeutic Drug Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Therapeutic Drug Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MtoZ-Biolabs
Charles River Laboratories
GenScript
Coriolis Pharma
Alloy Therapeutics
ProBio
Medicilon
GENECHEM
Shanghai InnoStar Bio-tech
SinoBiological
Wuxi Biologics
Abace Biotechnology
Levena Biopharma
XtalPi
Segment by Type
Antibody Drug Analysis Service
Antibody Drug Development Service
Others
Segment by Application
Monoclonal Antibody
Bisclonal Antibody
ADC
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Therapeutic Drug Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Therapeutic Drug Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibody Drug Analysis Service
1.2.3 Antibody Drug Development Service
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antibody Therapeutic Drug Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Monoclonal Antibody
1.3.3 Bisclonal Antibody
1.3.4 ADC
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Therapeutic Drug Services Market Perspective (2020-2031)
2.2 Global Antibody Therapeutic Drug Services Growth Trends by Region
2.2.1 Global Antibody Therapeutic Drug Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody Therapeutic Drug Services Historic Market Size by Region (2020-2025)
2.2.3 Antibody Therapeutic Drug Services Forecasted Market Size by Region (2026-2031)
2.3 Antibody Therapeutic Drug Services Market Dynamics
2.3.1 Antibody Therapeutic Drug Services Industry Trends
2.3.2 Antibody Therapeutic Drug Services Market Drivers
2.3.3 Antibody Therapeutic Drug Services Market Challenges
2.3.4 Antibody Therapeutic Drug Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Therapeutic Drug Services Players by Revenue
3.1.1 Global Top Antibody Therapeutic Drug Services Players by Revenue (2020-2025)
3.1.2 Global Antibody Therapeutic Drug Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Antibody Therapeutic Drug Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Therapeutic Drug Services Revenue
3.4 Global Antibody Therapeutic Drug Services Market Concentration Ratio
3.4.1 Global Antibody Therapeutic Drug Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Therapeutic Drug Services Revenue in 2024
3.5 Global Key Players of Antibody Therapeutic Drug Services Head office and Area Served
3.6 Global Key Players of Antibody Therapeutic Drug Services, Product and Application
3.7 Global Key Players of Antibody Therapeutic Drug Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Therapeutic Drug Services Breakdown Data by Type
4.1 Global Antibody Therapeutic Drug Services Historic Market Size by Type (2020-2025)
4.2 Global Antibody Therapeutic Drug Services Forecasted Market Size by Type (2026-2031)
5 Antibody Therapeutic Drug Services Breakdown Data by Application
5.1 Global Antibody Therapeutic Drug Services Historic Market Size by Application (2020-2025)
5.2 Global Antibody Therapeutic Drug Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody Therapeutic Drug Services Market Size (2020-2031)
6.2 North America Antibody Therapeutic Drug Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody Therapeutic Drug Services Market Size by Country (2020-2025)
6.4 North America Antibody Therapeutic Drug Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Therapeutic Drug Services Market Size (2020-2031)
7.2 Europe Antibody Therapeutic Drug Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody Therapeutic Drug Services Market Size by Country (2020-2025)
7.4 Europe Antibody Therapeutic Drug Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Therapeutic Drug Services Market Size (2020-2031)
8.2 Asia-Pacific Antibody Therapeutic Drug Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody Therapeutic Drug Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody Therapeutic Drug Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Therapeutic Drug Services Market Size (2020-2031)
9.2 Latin America Antibody Therapeutic Drug Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody Therapeutic Drug Services Market Size by Country (2020-2025)
9.4 Latin America Antibody Therapeutic Drug Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Therapeutic Drug Services Market Size (2020-2031)
10.2 Middle East & Africa Antibody Therapeutic Drug Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody Therapeutic Drug Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody Therapeutic Drug Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MtoZ-Biolabs
11.1.1 MtoZ-Biolabs Company Details
11.1.2 MtoZ-Biolabs Business Overview
11.1.3 MtoZ-Biolabs Antibody Therapeutic Drug Services Introduction
11.1.4 MtoZ-Biolabs Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.1.5 MtoZ-Biolabs Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Details
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Antibody Therapeutic Drug Services Introduction
11.2.4 Charles River Laboratories Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.2.5 Charles River Laboratories Recent Development
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript Antibody Therapeutic Drug Services Introduction
11.3.4 GenScript Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.3.5 GenScript Recent Development
11.4 Coriolis Pharma
11.4.1 Coriolis Pharma Company Details
11.4.2 Coriolis Pharma Business Overview
11.4.3 Coriolis Pharma Antibody Therapeutic Drug Services Introduction
11.4.4 Coriolis Pharma Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.4.5 Coriolis Pharma Recent Development
11.5 Alloy Therapeutics
11.5.1 Alloy Therapeutics Company Details
11.5.2 Alloy Therapeutics Business Overview
11.5.3 Alloy Therapeutics Antibody Therapeutic Drug Services Introduction
11.5.4 Alloy Therapeutics Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.5.5 Alloy Therapeutics Recent Development
11.6 ProBio
11.6.1 ProBio Company Details
11.6.2 ProBio Business Overview
11.6.3 ProBio Antibody Therapeutic Drug Services Introduction
11.6.4 ProBio Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.6.5 ProBio Recent Development
11.7 Medicilon
11.7.1 Medicilon Company Details
11.7.2 Medicilon Business Overview
11.7.3 Medicilon Antibody Therapeutic Drug Services Introduction
11.7.4 Medicilon Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.7.5 Medicilon Recent Development
11.8 GENECHEM
11.8.1 GENECHEM Company Details
11.8.2 GENECHEM Business Overview
11.8.3 GENECHEM Antibody Therapeutic Drug Services Introduction
11.8.4 GENECHEM Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.8.5 GENECHEM Recent Development
11.9 Shanghai InnoStar Bio-tech
11.9.1 Shanghai InnoStar Bio-tech Company Details
11.9.2 Shanghai InnoStar Bio-tech Business Overview
11.9.3 Shanghai InnoStar Bio-tech Antibody Therapeutic Drug Services Introduction
11.9.4 Shanghai InnoStar Bio-tech Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.9.5 Shanghai InnoStar Bio-tech Recent Development
11.10 SinoBiological
11.10.1 SinoBiological Company Details
11.10.2 SinoBiological Business Overview
11.10.3 SinoBiological Antibody Therapeutic Drug Services Introduction
11.10.4 SinoBiological Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.10.5 SinoBiological Recent Development
11.11 Wuxi Biologics
11.11.1 Wuxi Biologics Company Details
11.11.2 Wuxi Biologics Business Overview
11.11.3 Wuxi Biologics Antibody Therapeutic Drug Services Introduction
11.11.4 Wuxi Biologics Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.11.5 Wuxi Biologics Recent Development
11.12 Abace Biotechnology
11.12.1 Abace Biotechnology Company Details
11.12.2 Abace Biotechnology Business Overview
11.12.3 Abace Biotechnology Antibody Therapeutic Drug Services Introduction
11.12.4 Abace Biotechnology Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.12.5 Abace Biotechnology Recent Development
11.13 Levena Biopharma
11.13.1 Levena Biopharma Company Details
11.13.2 Levena Biopharma Business Overview
11.13.3 Levena Biopharma Antibody Therapeutic Drug Services Introduction
11.13.4 Levena Biopharma Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.13.5 Levena Biopharma Recent Development
11.14 XtalPi
11.14.1 XtalPi Company Details
11.14.2 XtalPi Business Overview
11.14.3 XtalPi Antibody Therapeutic Drug Services Introduction
11.14.4 XtalPi Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.14.5 XtalPi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Therapeutic Drug Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antibody Drug Analysis Service
1.2.3 Antibody Drug Development Service
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antibody Therapeutic Drug Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Monoclonal Antibody
1.3.3 Bisclonal Antibody
1.3.4 ADC
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Therapeutic Drug Services Market Perspective (2020-2031)
2.2 Global Antibody Therapeutic Drug Services Growth Trends by Region
2.2.1 Global Antibody Therapeutic Drug Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody Therapeutic Drug Services Historic Market Size by Region (2020-2025)
2.2.3 Antibody Therapeutic Drug Services Forecasted Market Size by Region (2026-2031)
2.3 Antibody Therapeutic Drug Services Market Dynamics
2.3.1 Antibody Therapeutic Drug Services Industry Trends
2.3.2 Antibody Therapeutic Drug Services Market Drivers
2.3.3 Antibody Therapeutic Drug Services Market Challenges
2.3.4 Antibody Therapeutic Drug Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Therapeutic Drug Services Players by Revenue
3.1.1 Global Top Antibody Therapeutic Drug Services Players by Revenue (2020-2025)
3.1.2 Global Antibody Therapeutic Drug Services Revenue Market Share by Players (2020-2025)
3.2 Global Top Antibody Therapeutic Drug Services Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Therapeutic Drug Services Revenue
3.4 Global Antibody Therapeutic Drug Services Market Concentration Ratio
3.4.1 Global Antibody Therapeutic Drug Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Therapeutic Drug Services Revenue in 2024
3.5 Global Key Players of Antibody Therapeutic Drug Services Head office and Area Served
3.6 Global Key Players of Antibody Therapeutic Drug Services, Product and Application
3.7 Global Key Players of Antibody Therapeutic Drug Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Therapeutic Drug Services Breakdown Data by Type
4.1 Global Antibody Therapeutic Drug Services Historic Market Size by Type (2020-2025)
4.2 Global Antibody Therapeutic Drug Services Forecasted Market Size by Type (2026-2031)
5 Antibody Therapeutic Drug Services Breakdown Data by Application
5.1 Global Antibody Therapeutic Drug Services Historic Market Size by Application (2020-2025)
5.2 Global Antibody Therapeutic Drug Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody Therapeutic Drug Services Market Size (2020-2031)
6.2 North America Antibody Therapeutic Drug Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody Therapeutic Drug Services Market Size by Country (2020-2025)
6.4 North America Antibody Therapeutic Drug Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Therapeutic Drug Services Market Size (2020-2031)
7.2 Europe Antibody Therapeutic Drug Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody Therapeutic Drug Services Market Size by Country (2020-2025)
7.4 Europe Antibody Therapeutic Drug Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Therapeutic Drug Services Market Size (2020-2031)
8.2 Asia-Pacific Antibody Therapeutic Drug Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody Therapeutic Drug Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody Therapeutic Drug Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Therapeutic Drug Services Market Size (2020-2031)
9.2 Latin America Antibody Therapeutic Drug Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody Therapeutic Drug Services Market Size by Country (2020-2025)
9.4 Latin America Antibody Therapeutic Drug Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Therapeutic Drug Services Market Size (2020-2031)
10.2 Middle East & Africa Antibody Therapeutic Drug Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody Therapeutic Drug Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody Therapeutic Drug Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 MtoZ-Biolabs
11.1.1 MtoZ-Biolabs Company Details
11.1.2 MtoZ-Biolabs Business Overview
11.1.3 MtoZ-Biolabs Antibody Therapeutic Drug Services Introduction
11.1.4 MtoZ-Biolabs Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.1.5 MtoZ-Biolabs Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Details
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories Antibody Therapeutic Drug Services Introduction
11.2.4 Charles River Laboratories Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.2.5 Charles River Laboratories Recent Development
11.3 GenScript
11.3.1 GenScript Company Details
11.3.2 GenScript Business Overview
11.3.3 GenScript Antibody Therapeutic Drug Services Introduction
11.3.4 GenScript Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.3.5 GenScript Recent Development
11.4 Coriolis Pharma
11.4.1 Coriolis Pharma Company Details
11.4.2 Coriolis Pharma Business Overview
11.4.3 Coriolis Pharma Antibody Therapeutic Drug Services Introduction
11.4.4 Coriolis Pharma Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.4.5 Coriolis Pharma Recent Development
11.5 Alloy Therapeutics
11.5.1 Alloy Therapeutics Company Details
11.5.2 Alloy Therapeutics Business Overview
11.5.3 Alloy Therapeutics Antibody Therapeutic Drug Services Introduction
11.5.4 Alloy Therapeutics Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.5.5 Alloy Therapeutics Recent Development
11.6 ProBio
11.6.1 ProBio Company Details
11.6.2 ProBio Business Overview
11.6.3 ProBio Antibody Therapeutic Drug Services Introduction
11.6.4 ProBio Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.6.5 ProBio Recent Development
11.7 Medicilon
11.7.1 Medicilon Company Details
11.7.2 Medicilon Business Overview
11.7.3 Medicilon Antibody Therapeutic Drug Services Introduction
11.7.4 Medicilon Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.7.5 Medicilon Recent Development
11.8 GENECHEM
11.8.1 GENECHEM Company Details
11.8.2 GENECHEM Business Overview
11.8.3 GENECHEM Antibody Therapeutic Drug Services Introduction
11.8.4 GENECHEM Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.8.5 GENECHEM Recent Development
11.9 Shanghai InnoStar Bio-tech
11.9.1 Shanghai InnoStar Bio-tech Company Details
11.9.2 Shanghai InnoStar Bio-tech Business Overview
11.9.3 Shanghai InnoStar Bio-tech Antibody Therapeutic Drug Services Introduction
11.9.4 Shanghai InnoStar Bio-tech Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.9.5 Shanghai InnoStar Bio-tech Recent Development
11.10 SinoBiological
11.10.1 SinoBiological Company Details
11.10.2 SinoBiological Business Overview
11.10.3 SinoBiological Antibody Therapeutic Drug Services Introduction
11.10.4 SinoBiological Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.10.5 SinoBiological Recent Development
11.11 Wuxi Biologics
11.11.1 Wuxi Biologics Company Details
11.11.2 Wuxi Biologics Business Overview
11.11.3 Wuxi Biologics Antibody Therapeutic Drug Services Introduction
11.11.4 Wuxi Biologics Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.11.5 Wuxi Biologics Recent Development
11.12 Abace Biotechnology
11.12.1 Abace Biotechnology Company Details
11.12.2 Abace Biotechnology Business Overview
11.12.3 Abace Biotechnology Antibody Therapeutic Drug Services Introduction
11.12.4 Abace Biotechnology Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.12.5 Abace Biotechnology Recent Development
11.13 Levena Biopharma
11.13.1 Levena Biopharma Company Details
11.13.2 Levena Biopharma Business Overview
11.13.3 Levena Biopharma Antibody Therapeutic Drug Services Introduction
11.13.4 Levena Biopharma Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.13.5 Levena Biopharma Recent Development
11.14 XtalPi
11.14.1 XtalPi Company Details
11.14.2 XtalPi Business Overview
11.14.3 XtalPi Antibody Therapeutic Drug Services Introduction
11.14.4 XtalPi Revenue in Antibody Therapeutic Drug Services Business (2020-2025)
11.14.5 XtalPi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antibody Therapeutic Drug Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibody Drug Analysis Service
Table 3. Key Players of Antibody Drug Development Service
Table 4. Key Players of Others
Table 5. Global Antibody Therapeutic Drug Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antibody Therapeutic Drug Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Antibody Therapeutic Drug Services Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Antibody Therapeutic Drug Services Market Share by Region (2020-2025)
Table 9. Global Antibody Therapeutic Drug Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Antibody Therapeutic Drug Services Market Share by Region (2026-2031)
Table 11. Antibody Therapeutic Drug Services Market Trends
Table 12. Antibody Therapeutic Drug Services Market Drivers
Table 13. Antibody Therapeutic Drug Services Market Challenges
Table 14. Antibody Therapeutic Drug Services Market Restraints
Table 15. Global Antibody Therapeutic Drug Services Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Antibody Therapeutic Drug Services Market Share by Players (2020-2025)
Table 17. Global Top Antibody Therapeutic Drug Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutic Drug Services as of 2024)
Table 18. Ranking of Global Top Antibody Therapeutic Drug Services Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Antibody Therapeutic Drug Services Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Antibody Therapeutic Drug Services, Headquarters and Area Served
Table 21. Global Key Players of Antibody Therapeutic Drug Services, Product and Application
Table 22. Global Key Players of Antibody Therapeutic Drug Services, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibody Therapeutic Drug Services Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Antibody Therapeutic Drug Services Revenue Market Share by Type (2020-2025)
Table 26. Global Antibody Therapeutic Drug Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Antibody Therapeutic Drug Services Revenue Market Share by Type (2026-2031)
Table 28. Global Antibody Therapeutic Drug Services Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Antibody Therapeutic Drug Services Revenue Market Share by Application (2020-2025)
Table 30. Global Antibody Therapeutic Drug Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Antibody Therapeutic Drug Services Revenue Market Share by Application (2026-2031)
Table 32. North America Antibody Therapeutic Drug Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Antibody Therapeutic Drug Services Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Antibody Therapeutic Drug Services Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Antibody Therapeutic Drug Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Antibody Therapeutic Drug Services Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Antibody Therapeutic Drug Services Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Antibody Therapeutic Drug Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Antibody Therapeutic Drug Services Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Antibody Therapeutic Drug Services Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Antibody Therapeutic Drug Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Antibody Therapeutic Drug Services Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Antibody Therapeutic Drug Services Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Antibody Therapeutic Drug Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Antibody Therapeutic Drug Services Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Antibody Therapeutic Drug Services Market Size by Country (2026-2031) & (US$ Million)
Table 47. MtoZ-Biolabs Company Details
Table 48. MtoZ-Biolabs Business Overview
Table 49. MtoZ-Biolabs Antibody Therapeutic Drug Services Product
Table 50. MtoZ-Biolabs Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 51. MtoZ-Biolabs Recent Development
Table 52. Charles River Laboratories Company Details
Table 53. Charles River Laboratories Business Overview
Table 54. Charles River Laboratories Antibody Therapeutic Drug Services Product
Table 55. Charles River Laboratories Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 56. Charles River Laboratories Recent Development
Table 57. GenScript Company Details
Table 58. GenScript Business Overview
Table 59. GenScript Antibody Therapeutic Drug Services Product
Table 60. GenScript Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 61. GenScript Recent Development
Table 62. Coriolis Pharma Company Details
Table 63. Coriolis Pharma Business Overview
Table 64. Coriolis Pharma Antibody Therapeutic Drug Services Product
Table 65. Coriolis Pharma Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 66. Coriolis Pharma Recent Development
Table 67. Alloy Therapeutics Company Details
Table 68. Alloy Therapeutics Business Overview
Table 69. Alloy Therapeutics Antibody Therapeutic Drug Services Product
Table 70. Alloy Therapeutics Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 71. Alloy Therapeutics Recent Development
Table 72. ProBio Company Details
Table 73. ProBio Business Overview
Table 74. ProBio Antibody Therapeutic Drug Services Product
Table 75. ProBio Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 76. ProBio Recent Development
Table 77. Medicilon Company Details
Table 78. Medicilon Business Overview
Table 79. Medicilon Antibody Therapeutic Drug Services Product
Table 80. Medicilon Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 81. Medicilon Recent Development
Table 82. GENECHEM Company Details
Table 83. GENECHEM Business Overview
Table 84. GENECHEM Antibody Therapeutic Drug Services Product
Table 85. GENECHEM Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 86. GENECHEM Recent Development
Table 87. Shanghai InnoStar Bio-tech Company Details
Table 88. Shanghai InnoStar Bio-tech Business Overview
Table 89. Shanghai InnoStar Bio-tech Antibody Therapeutic Drug Services Product
Table 90. Shanghai InnoStar Bio-tech Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 91. Shanghai InnoStar Bio-tech Recent Development
Table 92. SinoBiological Company Details
Table 93. SinoBiological Business Overview
Table 94. SinoBiological Antibody Therapeutic Drug Services Product
Table 95. SinoBiological Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 96. SinoBiological Recent Development
Table 97. Wuxi Biologics Company Details
Table 98. Wuxi Biologics Business Overview
Table 99. Wuxi Biologics Antibody Therapeutic Drug Services Product
Table 100. Wuxi Biologics Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 101. Wuxi Biologics Recent Development
Table 102. Abace Biotechnology Company Details
Table 103. Abace Biotechnology Business Overview
Table 104. Abace Biotechnology Antibody Therapeutic Drug Services Product
Table 105. Abace Biotechnology Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 106. Abace Biotechnology Recent Development
Table 107. Levena Biopharma Company Details
Table 108. Levena Biopharma Business Overview
Table 109. Levena Biopharma Antibody Therapeutic Drug Services Product
Table 110. Levena Biopharma Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 111. Levena Biopharma Recent Development
Table 112. XtalPi Company Details
Table 113. XtalPi Business Overview
Table 114. XtalPi Antibody Therapeutic Drug Services Product
Table 115. XtalPi Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 116. XtalPi Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Antibody Therapeutic Drug Services Picture
Figure 2. Global Antibody Therapeutic Drug Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibody Therapeutic Drug Services Market Share by Type: 2024 VS 2031
Figure 4. Antibody Drug Analysis Service Features
Figure 5. Antibody Drug Development Service Features
Figure 6. Others Features
Figure 7. Global Antibody Therapeutic Drug Services Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Antibody Therapeutic Drug Services Market Share by Application: 2024 VS 2031
Figure 9. Monoclonal Antibody Case Studies
Figure 10. Bisclonal Antibody Case Studies
Figure 11. ADC Case Studies
Figure 12. Others Case Studies
Figure 13. Antibody Therapeutic Drug Services Report Years Considered
Figure 14. Global Antibody Therapeutic Drug Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Antibody Therapeutic Drug Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Antibody Therapeutic Drug Services Market Share by Region: 2024 VS 2031
Figure 17. Global Antibody Therapeutic Drug Services Market Share by Players in 2024
Figure 18. Global Antibody Therapeutic Drug Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Antibody Therapeutic Drug Services Revenue in 2024
Figure 20. North America Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Antibody Therapeutic Drug Services Market Share by Country (2020-2031)
Figure 22. United States Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Antibody Therapeutic Drug Services Market Share by Country (2020-2031)
Figure 26. Germany Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Antibody Therapeutic Drug Services Market Share by Region (2020-2031)
Figure 34. China Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Antibody Therapeutic Drug Services Market Share by Country (2020-2031)
Figure 42. Mexico Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Antibody Therapeutic Drug Services Market Share by Country (2020-2031)
Figure 46. Turkey Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. MtoZ-Biolabs Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 50. Charles River Laboratories Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 51. GenScript Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 52. Coriolis Pharma Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 53. Alloy Therapeutics Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 54. ProBio Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 55. Medicilon Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 56. GENECHEM Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 57. Shanghai InnoStar Bio-tech Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 58. SinoBiological Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 59. Wuxi Biologics Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 60. Abace Biotechnology Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 61. Levena Biopharma Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 62. XtalPi Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Antibody Therapeutic Drug Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antibody Drug Analysis Service
Table 3. Key Players of Antibody Drug Development Service
Table 4. Key Players of Others
Table 5. Global Antibody Therapeutic Drug Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antibody Therapeutic Drug Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Antibody Therapeutic Drug Services Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Antibody Therapeutic Drug Services Market Share by Region (2020-2025)
Table 9. Global Antibody Therapeutic Drug Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Antibody Therapeutic Drug Services Market Share by Region (2026-2031)
Table 11. Antibody Therapeutic Drug Services Market Trends
Table 12. Antibody Therapeutic Drug Services Market Drivers
Table 13. Antibody Therapeutic Drug Services Market Challenges
Table 14. Antibody Therapeutic Drug Services Market Restraints
Table 15. Global Antibody Therapeutic Drug Services Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Antibody Therapeutic Drug Services Market Share by Players (2020-2025)
Table 17. Global Top Antibody Therapeutic Drug Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Therapeutic Drug Services as of 2024)
Table 18. Ranking of Global Top Antibody Therapeutic Drug Services Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Antibody Therapeutic Drug Services Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Antibody Therapeutic Drug Services, Headquarters and Area Served
Table 21. Global Key Players of Antibody Therapeutic Drug Services, Product and Application
Table 22. Global Key Players of Antibody Therapeutic Drug Services, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibody Therapeutic Drug Services Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Antibody Therapeutic Drug Services Revenue Market Share by Type (2020-2025)
Table 26. Global Antibody Therapeutic Drug Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Antibody Therapeutic Drug Services Revenue Market Share by Type (2026-2031)
Table 28. Global Antibody Therapeutic Drug Services Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Antibody Therapeutic Drug Services Revenue Market Share by Application (2020-2025)
Table 30. Global Antibody Therapeutic Drug Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Antibody Therapeutic Drug Services Revenue Market Share by Application (2026-2031)
Table 32. North America Antibody Therapeutic Drug Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Antibody Therapeutic Drug Services Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Antibody Therapeutic Drug Services Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Antibody Therapeutic Drug Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Antibody Therapeutic Drug Services Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Antibody Therapeutic Drug Services Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Antibody Therapeutic Drug Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Antibody Therapeutic Drug Services Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Antibody Therapeutic Drug Services Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Antibody Therapeutic Drug Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Antibody Therapeutic Drug Services Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Antibody Therapeutic Drug Services Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Antibody Therapeutic Drug Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Antibody Therapeutic Drug Services Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Antibody Therapeutic Drug Services Market Size by Country (2026-2031) & (US$ Million)
Table 47. MtoZ-Biolabs Company Details
Table 48. MtoZ-Biolabs Business Overview
Table 49. MtoZ-Biolabs Antibody Therapeutic Drug Services Product
Table 50. MtoZ-Biolabs Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 51. MtoZ-Biolabs Recent Development
Table 52. Charles River Laboratories Company Details
Table 53. Charles River Laboratories Business Overview
Table 54. Charles River Laboratories Antibody Therapeutic Drug Services Product
Table 55. Charles River Laboratories Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 56. Charles River Laboratories Recent Development
Table 57. GenScript Company Details
Table 58. GenScript Business Overview
Table 59. GenScript Antibody Therapeutic Drug Services Product
Table 60. GenScript Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 61. GenScript Recent Development
Table 62. Coriolis Pharma Company Details
Table 63. Coriolis Pharma Business Overview
Table 64. Coriolis Pharma Antibody Therapeutic Drug Services Product
Table 65. Coriolis Pharma Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 66. Coriolis Pharma Recent Development
Table 67. Alloy Therapeutics Company Details
Table 68. Alloy Therapeutics Business Overview
Table 69. Alloy Therapeutics Antibody Therapeutic Drug Services Product
Table 70. Alloy Therapeutics Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 71. Alloy Therapeutics Recent Development
Table 72. ProBio Company Details
Table 73. ProBio Business Overview
Table 74. ProBio Antibody Therapeutic Drug Services Product
Table 75. ProBio Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 76. ProBio Recent Development
Table 77. Medicilon Company Details
Table 78. Medicilon Business Overview
Table 79. Medicilon Antibody Therapeutic Drug Services Product
Table 80. Medicilon Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 81. Medicilon Recent Development
Table 82. GENECHEM Company Details
Table 83. GENECHEM Business Overview
Table 84. GENECHEM Antibody Therapeutic Drug Services Product
Table 85. GENECHEM Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 86. GENECHEM Recent Development
Table 87. Shanghai InnoStar Bio-tech Company Details
Table 88. Shanghai InnoStar Bio-tech Business Overview
Table 89. Shanghai InnoStar Bio-tech Antibody Therapeutic Drug Services Product
Table 90. Shanghai InnoStar Bio-tech Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 91. Shanghai InnoStar Bio-tech Recent Development
Table 92. SinoBiological Company Details
Table 93. SinoBiological Business Overview
Table 94. SinoBiological Antibody Therapeutic Drug Services Product
Table 95. SinoBiological Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 96. SinoBiological Recent Development
Table 97. Wuxi Biologics Company Details
Table 98. Wuxi Biologics Business Overview
Table 99. Wuxi Biologics Antibody Therapeutic Drug Services Product
Table 100. Wuxi Biologics Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 101. Wuxi Biologics Recent Development
Table 102. Abace Biotechnology Company Details
Table 103. Abace Biotechnology Business Overview
Table 104. Abace Biotechnology Antibody Therapeutic Drug Services Product
Table 105. Abace Biotechnology Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 106. Abace Biotechnology Recent Development
Table 107. Levena Biopharma Company Details
Table 108. Levena Biopharma Business Overview
Table 109. Levena Biopharma Antibody Therapeutic Drug Services Product
Table 110. Levena Biopharma Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 111. Levena Biopharma Recent Development
Table 112. XtalPi Company Details
Table 113. XtalPi Business Overview
Table 114. XtalPi Antibody Therapeutic Drug Services Product
Table 115. XtalPi Revenue in Antibody Therapeutic Drug Services Business (2020-2025) & (US$ Million)
Table 116. XtalPi Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Antibody Therapeutic Drug Services Picture
Figure 2. Global Antibody Therapeutic Drug Services Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibody Therapeutic Drug Services Market Share by Type: 2024 VS 2031
Figure 4. Antibody Drug Analysis Service Features
Figure 5. Antibody Drug Development Service Features
Figure 6. Others Features
Figure 7. Global Antibody Therapeutic Drug Services Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Antibody Therapeutic Drug Services Market Share by Application: 2024 VS 2031
Figure 9. Monoclonal Antibody Case Studies
Figure 10. Bisclonal Antibody Case Studies
Figure 11. ADC Case Studies
Figure 12. Others Case Studies
Figure 13. Antibody Therapeutic Drug Services Report Years Considered
Figure 14. Global Antibody Therapeutic Drug Services Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Antibody Therapeutic Drug Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Antibody Therapeutic Drug Services Market Share by Region: 2024 VS 2031
Figure 17. Global Antibody Therapeutic Drug Services Market Share by Players in 2024
Figure 18. Global Antibody Therapeutic Drug Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Antibody Therapeutic Drug Services Revenue in 2024
Figure 20. North America Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Antibody Therapeutic Drug Services Market Share by Country (2020-2031)
Figure 22. United States Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Antibody Therapeutic Drug Services Market Share by Country (2020-2031)
Figure 26. Germany Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Antibody Therapeutic Drug Services Market Share by Region (2020-2031)
Figure 34. China Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Antibody Therapeutic Drug Services Market Share by Country (2020-2031)
Figure 42. Mexico Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Antibody Therapeutic Drug Services Market Share by Country (2020-2031)
Figure 46. Turkey Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Antibody Therapeutic Drug Services Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. MtoZ-Biolabs Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 50. Charles River Laboratories Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 51. GenScript Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 52. Coriolis Pharma Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 53. Alloy Therapeutics Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 54. ProBio Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 55. Medicilon Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 56. GENECHEM Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 57. Shanghai InnoStar Bio-tech Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 58. SinoBiological Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 59. Wuxi Biologics Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 60. Abace Biotechnology Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 61. Levena Biopharma Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 62. XtalPi Revenue Growth Rate in Antibody Therapeutic Drug Services Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232